01 1Active Pharma Inc.
02 1H. Lundbeck A/S
03 2Hetero Labs Limited
04 1Hwail Pharmaceutical Co. , Ltd.
05 1MICRO LABS LIMITED.
06 1Sun Chemical Co., Ltd.
07 2Synergene Active Ingredients Pvt. Ltd.
08 1Tokuyama Corporation
09 1Zhejiang Huahai Pharmaceutical Co. , Ltd.
01 8Escitalopram Oxalate
02 1Escitalopram Oxate
03 1Escitalopram oxalate
04 1Escitalopram oxalate [D]
01 2China
02 1Denmark
03 5India
04 2Japan
05 1South Korea
Registration Number : 222MF10216
Registrant's Address : Ottiliavej 9, DK-2500, Valby, Copenhagen, Denmark
Initial Date of Registration : 2010-08-10
Latest Date of Registration : 2020-06-11
Registration Number : 303MF10125
Registrant's Address : 7-2-A2,Hetero Corporate,Industrial Estates Sanath Nagar,Hyderabad-500 018 Telangana I...
Initial Date of Registration : 2021-08-16
Latest Date of Registration : 2022-05-12
Registration Number : 303MF10131
Registrant's Address : 57, Jeyakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea
Initial Date of Registration : 2021-08-16
Latest Date of Registration : 2021-08-16
Registration Number : 303MF10028
Registrant's Address : 31, Race Course Road, Bengaluru-560 001, KARNATAKA, INDIA
Initial Date of Registration : 2021-02-10
Latest Date of Registration : 2022-05-18
Registration Number : 303MF10126
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2021-08-16
Latest Date of Registration : 2021-08-16
Registration Number : 303MF10139
Registrant's Address : Flat No. 402,Bhanu Enclave,Sunder Nagar,Erragadda,Hyderabad-500 038,Telangana,India
Initial Date of Registration : 2021-08-25
Latest Date of Registration : 2021-08-25
Registration Number : 303MF10120
Registrant's Address : Flat No. 402,Bhanu Enclave,Sunder Nagar,Erragadda,Hyderabad-500 038,Telangana,India
Initial Date of Registration : 2021-08-02
Latest Date of Registration : 2021-08-02
Registration Number : 303MF10118
Registrant's Address : 1-1 Mikage-cho, Shunan City, Yamaguchi Prefecture
Initial Date of Registration : 2021-07-28
Latest Date of Registration : 2021-07-28
Registration Number : 303MF10122
Registrant's Address : 29-3 Shinmachi, Yashio City, Saitama Prefecture
Initial Date of Registration : 2021-08-02
Latest Date of Registration : 2021-08-02
Registration Number : 303MF10128
Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China
Initial Date of Registration : 2021-08-16
Latest Date of Registration : 2021-08-16
A Escitalopram Oxalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Escitalopram Oxalate, including repackagers and relabelers. The FDA regulates Escitalopram Oxalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Escitalopram Oxalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Escitalopram Oxalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Escitalopram Oxalate supplier is an individual or a company that provides Escitalopram Oxalate active pharmaceutical ingredient (API) or Escitalopram Oxalate finished formulations upon request. The Escitalopram Oxalate suppliers may include Escitalopram Oxalate API manufacturers, exporters, distributors and traders.
click here to find a list of Escitalopram Oxalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Escitalopram Oxalate Drug Master File in Japan (Escitalopram Oxalate JDMF) empowers Escitalopram Oxalate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Escitalopram Oxalate JDMF during the approval evaluation for pharmaceutical products. At the time of Escitalopram Oxalate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Escitalopram Oxalate suppliers with JDMF on PharmaCompass.
We have 9 companies offering Escitalopram Oxalate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
